Esonarimod | Interleukin Related interleukin-related.com

Product Name :
Esonarimod

Search keywords :
Esonarimod

drugId :
null

Target Vo:
Interleukin-1 alpha

Target Vo Short Name :
IL1A

Moa_Name:
Interleukin-1 alpha inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Taisho Pharmaceutical Co Ltd

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Arthritis, Rheumatoid

Termination Status :
Phase 3 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PDCD4 Rabbit mAb Description
Hsp27 (YP6091) Mouse mAb custom synthesis
Phospho-CDK1 (Tyr15) Antibody: Phospho-CDK1 (Tyr15) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 34 kDa, targeting to Phospho-CDK1 (Tyr15). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts